jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 16, 2022

June. 16, 2022

jRCT1050220051

Evaluation of knee function and safety after treatment of articular cartilage damage in knee joints with allogeneic induced pluripotent stem (iPS) cell-derived cartilage.

Evaluation of knee function and safety after treatment of knee articular cartilage damage with iPS-cell-derived cartilage.

Matsuda Shuichi

Kyoto University Hospital

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

+81-75-751-3366

seikei@kuhp.kyoto-u.ac.jp

Kuriyama Shinichi

Kyoto University Hospital

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

+81-75-751-3366

seikei@kuhp.kyoto-u.ac.jp

Recruiting

June. 16, 2022

4

Observational

Patients who received and completed knee treatment with iPS-cell-derived cartilage.

Patients whom the doctors considered inappropriate for the study.
1) Patients with new-onset systematic diseases unrelated to the surgery that can not come to the hospital..
2) Patients who have difficulty coming to the hospital due to relocation.
3) Patients with new-onset psychiatric disorders that may influence the conduct and evaluation of this study.

20age old over
No limit

Both

Damage of articular cartilage of the Knee

Articular cartilage damage, Articular cartilage disorder, Osteoarthritis

Evaluation of clinical outcomes of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.

Evaluation of safety of patients who received treatment with iPS-cell-derived cartilage for at least one year postoperatively.

Kyoto University Hospital
Kyoto University Graduate School and Faculty of Medicine, Ethics Committee
Yoshida-Konoecho, Sakyo-ku, Kyoto, Kyoto

+81-75-753-4680

ethcom@kuhp.kyoto-u.ac.jp
Approval

No

none